{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:53:37Z","timestamp":1786985617794,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.canrad.2017.07.036","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T02:12:11Z","timestamp":1504663931000},"page":"613-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Contraintes de doses aux organes \u00e0 risque en radioth\u00e9rapie conformationnelle et st\u00e9r\u00e9otaxique\u00a0: intestin gr\u00eale et duod\u00e9num"],"prefix":"10.1016","volume":"21","author":[{"given":"F.","family":"Goupy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Chajon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9.","family":"Le Pris\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Duverg\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Jaksic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Vogin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9.","family":"Monpetit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"de Bossch\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Maingon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2017.07.036_bib0005","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/1097-0142(196810)22:4<767::AID-CNCR2820220412>3.0.CO;2-7","article-title":"Clinical radiation pathology as applied to curative radiotherapy","volume":"22","author":"Rubin","year":"1968","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2017.07.036_bib0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.canrad.2004.03.003","article-title":"Organes critiques et irradiation externe des cancers gyn\u00e9cologiques\u00a0: l\u2019eau peut-elle \u00eatre utilis\u00e9e comme produit de contraste pour faciliter la d\u00e9lin\u00e9ation de l\u2019intestin gr\u00eale\u00a0?","volume":"8","author":"Firouzmand","year":"2004","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2017.07.036_bib0015","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0360-3016(01)01804-1","article-title":"The position and volume of the small bowel during adjuvant radiation therapy for rectal cancer","volume":"51","author":"Nuyttens","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/PL00002334","volume":"176","author":"K\u00f6lbl","year":"2000","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0025","first-page":"357","article-title":"Bowel injury: current and evolving management strategies","volume":"13","author":"Hauer-Jensen","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0030","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.clon.2009.10.003","article-title":"Chronic radiation enteritis","volume":"22","author":"Theis","year":"2010","journal-title":"Clin Oncol R Coll Radiol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1748-717X-6-47","article-title":"Laparoscopic insertion of pelvic tissue expander to prevent radiation enteritis prior to radiotherapy for prostate cancer","volume":"6","author":"McKay","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijsu.2015.08.082","article-title":"Laparoscopic pelvic mesh placement with closure of pelvic floor entrance to prevent small intestine radiation trauma - a retrospective cohort analysis","volume":"23","author":"Bachmann","year":"2015","journal-title":"Int J Surg"},{"key":"10.1016\/j.canrad.2017.07.036_bib0045","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1055\/s-2007-970202","article-title":"Radiation colitis and proctitis","volume":"20","author":"Kennedy","year":"2007","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.canrad.2017.07.036_bib0050","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ijrobp.2005.10.007","article-title":"A modified inflammatory bowel disease questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading","volume":"64","author":"Khalid","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0055","doi-asserted-by":"crossref","first-page":"917941","DOI":"10.1155\/2011\/917941","article-title":"Radiation proctitis: current strategies in management","volume":"2011","author":"Do","year":"2011","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.canrad.2017.07.036_bib0060","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.3748\/wjg.14.7289","article-title":"Recent advances in the management of radiation colitis","volume":"14","author":"Kountouras","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0065","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S1470-2045(07)70341-8","article-title":"Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients","volume":"8","author":"Andreyev","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0070","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/sj.bjc.6602552","article-title":"A modified inflammatory bowel disease questionnaire and the Vaizey incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy","volume":"92","author":"Olopade","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2017.07.036_bib0075","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/02841860701348670","article-title":"Late adverse effects of radiation therapy for rectal cancer - a systematic overview","volume":"46","author":"Birgisson","year":"2007","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0080","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<968::AID-CNCR5>3.0.CO;2-8","article-title":"Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials","volume":"78","author":"Holm","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2017.07.036_bib0085","unstructured":"CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf [Internet]. [cited 2017 May 7]. Available from: https:\/\/www.eortc.be\/services\/doc\/ctc\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf."},{"key":"10.1016\/j.canrad.2017.07.036_bib0090","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0360-3016(01)01820-X","article-title":"The dose\u2013volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer","volume":"52","author":"Baglan","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijrobp.2007.06.066","article-title":"The dose\u2013volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer","volume":"70","author":"Robertson","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0100","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.ijrobp.2011.09.022","article-title":"Dose\u2013volume analysis of predictors for gastrointestinal toxicity after concurrent full-dose gemcitabine and radiotherapy for locally advanced pancreatic adenocarcinoma","volume":"83","author":"Huang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijrobp.2008.10.086","article-title":"Dose\u2013volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer","volume":"75","author":"Fiorino","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2008.01.015","article-title":"Comparison of three strategies to delineate the bowel for whole pelvis IMRT of prostate cancer","volume":"88","author":"Sanguineti","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0120","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ijrobp.2009.08.075","article-title":"Guest editor's introduction to QUANTEC: a users guide","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0125","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.radonc.2003.05.001","article-title":"A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy","volume":"69","author":"Roeske","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0135","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ijrobp.2007.03.060","article-title":"The different volume effects of small-bowel toxicity during pelvic irradiation between gynecologic patients with and without abdominal surgery: a prospective study with computed tomography-based dosimetry","volume":"69","author":"Huang","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1634\/theoncologist.7-2-136","article-title":"The effect of nonmalignant systemic disease on tolerance to radiation therapy","volume":"7","author":"Chon","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.canrad.2017.07.036_bib0145","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","article-title":"Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma","volume":"340","author":"Keys","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2017.07.036_bib0150","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.ijrobp.2004.12.074","article-title":"A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282","volume":"62","author":"Cohen","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0155","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0360-3016(00)00653-2","article-title":"Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer","volume":"48","author":"Nutting","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0360-3016(01)01664-9","article-title":"Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation","volume":"51","author":"Portelance","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0165","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.ijrobp.2005.12.056","article-title":"Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels","volume":"65","author":"Guerrero Urbano","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/0284186X.2013.820342","article-title":"Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients","volume":"53","author":"Sanuki","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0175","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.3748\/wjg.v20.i15.4220","article-title":"Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer","volume":"20","author":"Takeda","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0180","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.clon.2015.01.030","article-title":"Stereotactic body radiotherapy for spinal and bone metastases","volume":"27","author":"Bhattacharya","year":"2015","journal-title":"Clin Oncol R Coll Radiol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0185","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/07357907.2016.1197235","article-title":"Role of stereotactic body radiation therapy with volumetric-modulated arcs and high-intensity photon beams for the treatment of abdomino-pelvic lymph-node metastases","volume":"34","author":"Franzese","year":"2016","journal-title":"Cancer Invest"},{"key":"10.1016\/j.canrad.2017.07.036_bib0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.semradonc.2008.04.001","article-title":"An overview of hypofractionation and introduction to this issue of seminars in radiation oncology","volume":"18","author":"Timmerman","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0195","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1120\/jacmp.v12i2.3368","article-title":"Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy","volume":"12","author":"Grimm","year":"2011","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.semradonc.2015.11.009","article-title":"Small bowel dose tolerance for stereotactic body radiation therapy","volume":"26","author":"LaCouture","year":"2016","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0205","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semradonc.2015.11.005","article-title":"Introduction and clinical overview of the DVH risk map","volume":"26","author":"Asbell","year":"2016","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0210","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semradonc.2015.12.002","article-title":"Dose\u2013volume histogram analysis of stereotactic body radiotherapy treatment of pancreatic cancer: a focus on duodenal dose constraints","volume":"26","author":"Goldsmith","year":"2016","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0215","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.canrad.2016.07.032","article-title":"D\u00e9lin\u00e9ation des organes \u00e0 risque et contraintes dosim\u00e9triques","volume":"20","author":"No\u00ebl","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2017.07.036_bib0220","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ijrobp.2009.08.046","article-title":"Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer","volume":"78","author":"Mahadevan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ctrv.2016.11.013","article-title":"Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: a systematic review","volume":"53","author":"Kroeze","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.canrad.2017.07.036_bib0230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2013.05.012","article-title":"Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT)","volume":"87","author":"Barney","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0235","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2017.07.036_bib0240","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ijrobp.2015.11.048","article-title":"Phase 1 trial of sorafenib and stereotactic body radiation therapy for hepatocellular carcinoma","volume":"94","author":"Brade","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0245","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1464-410X.2010.09895.x","article-title":"Simultaneous antiangiogenic therapy and single-fraction radiosurgery in clinically relevant metastases from renal cell carcinoma","volume":"108","author":"Staehler","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.canrad.2017.07.036_bib0250","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1200\/JCO.2012.47.7455","article-title":"Ablation of a site of progression with stereotactic body radiation therapy extends sunitinib treatment from 14 to 22 months","volume":"31","author":"Straka","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0255","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1200\/JCO.2014.56.7412","article-title":"trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer","volume":"32","author":"Iyengar","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0260","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ijrobp.2013.11.010","article-title":"Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinib","volume":"88","author":"Gan","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.07.036_bib0265","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/JTO.0b013e3182745948","article-title":"Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer","volume":"7","author":"Weickhardt","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0270","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1158\/2326-6066.CIR-13-0115","article-title":"An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer","volume":"1","author":"Golden","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.canrad.2017.07.036_bib0275","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1593\/tlo.12280","article-title":"A systemic complete response of metastatic melanoma to local radiation and immunotherapy","volume":"5","author":"Hiniker","year":"2012","journal-title":"Transl Oncol"},{"key":"10.1016\/j.canrad.2017.07.036_bib0280","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.canrad.2014.05.007","article-title":"Association d\u2019une chimioth\u00e9rapie ou d\u2019un traitement cibl\u00e9 \u00e0 une irradiation st\u00e9r\u00e9otaxique\u00a0: \u00e9tat des lieux et recommandations pr\u00e9liminaires","volume":"18","author":"Thariat","year":"2014","journal-title":"Cancer Radiother"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321817303293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321817303293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:28:34Z","timestamp":1761136114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321817303293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":56,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1278321817303293"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2017.07.036","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contraintes de doses aux organes \u00e0 risque en radioth\u00e9rapie conformationnelle et st\u00e9r\u00e9otaxique\u00a0: intestin gr\u00eale et duod\u00e9num","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2017.07.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}